Lv1
30 积分 2025-10-25 加入
The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravir
3个月前
已完结
The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
3个月前
已完结
Genetic engineering of systemically injectable oncolytic viruses for pyroptosis-accelerated cancer virotherapy
4个月前
已完结
Therapy with oncolytic viruses: progress and challenges
5个月前
已完结
Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial
5个月前
已完结
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
6个月前
已完结
Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response
10个月前
已完结
An oncolytic virus–T cell chimera for cancer immunotherapy
10个月前
已完结
皖公网安备34019202002308
